Efficacy of Subcutaneous Injection of Etanercept for Moderate and Severe Knee Osteoarthritis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Primary aim: evaluate efficacy of subcutaneous injection of etanercept for moderate and severe knee osteoarthritis. Second aim: investigate the potentiality of serum cytokines (TNF-α, Interleukin 1-α (IL1-α), IL1-β, matrix metalloproteinases1 (MMP1), MMP13) to predict the response of subcutaneous injection of etanercept for moderate and severe knee osteoarthritis.
Epistemonikos ID: b1905d37e8108e60b1bae18bf9729e4309d83611
First added on: May 12, 2024